Published in J Thorac Cardiovasc Surg on January 01, 1991
KRAS codon 61, 146 and BRAF mutations predict resistance to cetuximab plus irinotecan in KRAS codon 12 and 13 wild-type metastatic colorectal cancer. Br J Cancer (2009) 3.73
Effect of medical and surgical therapy on aortic dissection evaluated by transesophageal echocardiography. Implications for prognosis and therapy. The European Cooperative Study Group on Echocardiography. Circulation (1993) 2.74
Ascending aorta dissection after aortic valve replacement. J Heart Valve Dis (1998) 2.05
Quantitative PCR detection of t(11;14) bcl-1/JH in mantle cell lymphoma patients: comparison of peripheral blood and bone marrow aspirate samples. Eur Rev Med Pharmacol Sci (2015) 2.04
Natural history of bone metastasis in colorectal cancer: final results of a large Italian bone metastases study. Ann Oncol (2012) 1.78
Unveiling the timescale of the R-T transition in human hemoglobin. J Mol Biol (2010) 1.65
Vascular prostacyclin is increased in patients ingesting omega-3 polyunsaturated fatty acids before coronary artery bypass graft surgery. Circulation (1990) 1.63
Genetic modulation of the Let-7 microRNA binding to KRAS 3'-untranslated region and survival of metastatic colorectal cancer patients treated with salvage cetuximab-irinotecan. Pharmacogenomics J (2010) 1.63
Long-term effects of carvedilol in idiopathic dilated cardiomyopathy with persistent left ventricular dysfunction despite chronic metoprolol. The Heart-Muscle Disease Study Group. J Am Coll Cardiol (1999) 1.51
Proteolysis of von Willebrand factor and shear stress-induced platelet aggregation in patients with aortic valve stenosis. Circulation (2000) 1.48
'White-coat' hypertension in patients with newly diagnosed hypertension: evaluation of prevalence by ambulatory monitoring and impact on cost of health care. Eur Heart J (1995) 1.47
Oral allergy syndrome to grapes. Allergy (1998) 1.45
Midterm angiographic study of five recycled mammary arteries during four coronary redos. Ann Thorac Surg (1996) 1.42
Complement receptor (CR1) and IgG or IgA on erythrocytes and in circulating immune complexes in patients with glomerulonephritis. Nephrol Dial Transplant (1989) 1.42
Ambulatory follow-up of aortic dissection: comparison between computed tomography and biplane transesophageal echocardiography. Int J Card Imaging (1996) 1.39
Hemodynamic performance of the Edwards Prima stentless valve. J Heart Valve Dis (1997) 1.39
Histopathologic evaluation of liver metastases from colorectal cancer in patients treated with FOLFOXIRI plus bevacizumab. Br J Cancer (2013) 1.37
Differential pH sensitivity of Kir4.1 and Kir4.2 potassium channels and their modulation by heteropolymerisation with Kir5.1. J Physiol (2001) 1.33
Functional identification of rat atypical beta-adrenoceptors by the first beta 3-selective antagonists, aryloxypropanolaminotetralins. Br J Pharmacol (1996) 1.32
p38alpha blockade inhibits colorectal cancer growth in vivo by inducing a switch from HIF1alpha- to FoxO-dependent transcription. Cell Death Differ (2009) 1.30
pH dependence of the inwardly rectifying potassium channel, Kir5.1, and localization in renal tubular epithelia. J Biol Chem (2000) 1.24
Safety of intravenous high-dose dipyridamole echocardiography. The Echo-Persantine International Cooperative Study Group. Am J Cardiol (1992) 1.18
Estrogens and glucocorticoids inhibit endothelial vascular cell adhesion molecule-1 expression by different transcriptional mechanisms. Circ Res (2000) 1.12
Thoracolumbar disc extrusion associated with extensive epidural haemorrhage: a retrospective study of 23 dogs. J Small Anim Pract (2005) 1.10
Pharmacodynamic and pharmacogenetic angiogenesis-related markers of first-line FOLFOXIRI plus bevacizumab schedule in metastatic colorectal cancer. Br J Cancer (2011) 1.07
The G-protein-coupled receptor kinase GRK4 mediates homologous desensitization of metabotropic glutamate receptor 1. FASEB J (2000) 1.07
Expression of metabotropic glutamate receptors in the rat and human testis. J Endocrinol (2001) 1.06
Thyrotropin activates mitogen-activated protein kinase pathway in FRTL-5 by a cAMP-dependent protein kinase A-independent mechanism. Mol Pharmacol (2001) 1.05
Psychological and symptom distress in terminal cancer patients with met and unmet needs. J Pain Symptom Manage (1999) 1.04
Multimodal treatment to prevent the late whiplash syndrome. Scand J Rehabil Med (1996) 1.04
A phase II trial of 5-fluorouracil and high-dose intravenous leucovorin in gastric carcinoma. J Clin Oncol (1987) 1.01
Treatment of end-stage congestive heart failure by extracorporeal ultrafiltration. Am J Cardiol (1987) 1.01
Apparent diffusion coefficient obtained by magnetic resonance imaging as a prognostic marker in glioblastomas: correlation with MGMT promoter methylation status. Eur Radiol (2012) 1.01
Immunochemical versus guaiac occult blood stool tests: results of a community-based screening program. Surg Oncol (1994) 1.01
Bleeding time and bleeding: an analysis of the relationship of the bleeding time test with parameters of surgical bleeding. Blood (1994) 1.01
An EZH2 polymorphism is associated with clinical outcome in metastatic colorectal cancer patients. Ann Oncol (2011) 1.00
Myocardial revascularization procedures on multisegment diseased left anterior descending artery: endarterectomy or multiple sequential anastomoses (jumping)? Minerva Cardioangiol (1996) 1.00
Interaction of cAMP with the CDC25-mediated step in the cell cycle of budding yeast. Exp Cell Res (1986) 0.96
The immune response to influenza vaccination in diabetic patients. Diabetologia (1986) 0.95
Vaccination of sheep with purified cysteine proteinases of Fasciola hepatica decreases worm fecundity. Exp Parasitol (1994) 0.94
Circulating levels of cardiac natriuretic peptides (ANP and BNP) measured by highly sensitive and specific immunoradiometric assays in normal subjects and in patients with different degrees of heart failure. J Endocrinol Invest (1998) 0.93
Predicting outcome after myocardial revascularization in patients with left ventricular dysfunction. Cardiovasc Surg (1998) 0.92
The secreted cathepsin L-like proteinases of the trematode, Fasciola hepatica, contain 3-hydroxyproline residues. Biochem J (1994) 0.92
Prognosis of mucinous histology for patients with radically resected stage II and III colon cancer. Ann Oncol (2011) 0.92
Primary sequence heterogeneity and tissue expression of glutathione S-transferases of Fasciola hepatica. Exp Parasitol (1992) 0.91
Attenuated familial adenomatous polyposis and Muir-Torre syndrome linked to compound biallelic constitutional MYH gene mutations. Clin Genet (2005) 0.90
Native group-III metabotropic glutamate receptors are coupled to the mitogen-activated protein kinase/phosphatidylinositol-3-kinase pathways. J Neurochem (2002) 0.90
Nocturnal enuresis and daytime wetting: a multicentric trial with oxybutynin and desmopressin. Eur Urol (1997) 0.90
Pro-inflammatory/anti-inflammatory cytokine imbalance in acute coronary syndromes. Clin Exp Med (2006) 0.89
A mononucleotide markers panel to identify hMLH1/hMSH2 germline mutations. Dis Markers (2007) 0.88
Vaccination of sheep against Fasciola hepatica with glutathione S-transferase. Identification and mapping of antibody epitopes on a three-dimensional model of the antigen. J Immunol (1994) 0.88
Glucose metabolism and insulin secretion in the newborn infant. Comparisons between the responses observed the first and seventh day of life to intravenous and oral glucose tolerance tests. Diabetes (1974) 0.87
The radial artery: which place in coronary operation? Ann Thorac Surg (2000) 0.87
Valve-related complications in elderly patients with biological and mechanical aortic valves. Ann Thorac Surg (1998) 0.87
Frequency of constitutional MSH6 mutations in a consecutive series of families with clinical suspicion of HNPCC. Clin Genet (2007) 0.86
Macromolecular syntheses in the cell cycle mutant cdc25 of budding yeast. Eur J Biochem (1984) 0.86
[Use of serum cholinesterases in severe organophosphorus poisoning. Our experience]. Minerva Anestesiol (1989) 0.86
Immunological effects of bevacizumab-based treatment in metastatic colorectal cancer. Oncology (2011) 0.86
Structure and dynamics of water confined in silica hydrogels: X-ray scattering and dielectric spectroscopy studies. Eur Phys J E Soft Matter (2003) 0.86
Improving hemostasis during replacement of the ascending aorta and aortic valve with a composite graft. Tex Heart Inst J (2000) 0.85
Human endothelial cell damage by neutrophil-derived cathepsin G. Role of cytoskeleton rearrangement and matrix-bound plasminogen activator inhibitor-1. Arterioscler Thromb Vasc Biol (1995) 0.85
Familiar clustering of aortic dissection in polycystic kidney disease. Am J Cardiol (1993) 0.85
Off-pump redo coronary artery bypass grafting: technical aspects and early results. Heart Surg Forum (2002) 0.85
Left ventricular shape changes induced by aneurysmectomy with endoventricular circular patch plasty reconstruction. Eur Heart J (1994) 0.84
The application of bioactive compounds from the food industry to control mold growth in indoor waterborne coatings. Colloids Surf B Biointerfaces (2012) 0.84
Signal-averaged ECG abnormalities in haemodialysis patients. Role of dialysis. Nephrol Dial Transplant (1998) 0.84
Closed versus open endotracheal suctioning in preterm infants: effects on cerebral oxygenation and blood volume. Biol Neonate (1997) 0.84
Regional myocardial performance of non-ischaemic zones remote from anterior wall left ventricular aneurysm. Effects of aneurysmectomy. Eur Heart J (1995) 0.84
Intramedullary hemangioblastoma in a dog. Vet Pathol (2003) 0.83
High concordance of BRAF status between primary colorectal tumours and related metastatic sites: implications for clinical practice. Ann Oncol (2010) 0.83
EZH2 polymorphism and benefit from bevacizumab in colorectal cancer: another piece to the puzzle. Ann Oncol (2012) 0.83
Impaired left ventricular diastolic function and vascular postischemic vasodilation associated with microalbuminuria in IDDM patients. Diabetes Care (1995) 0.82
Medroxyprogesterone acetate at very high doses in postmenopausal advanced breast cancer patients. Chemioterapia (1987) 0.82
Molecular cloning and regulation of the expression of the MET2 gene of Saccharomyces cerevisiae. Gene (1986) 0.82
[Pseudoaneurysm of a branch of the internal mammary artery in a case operated on for aortic coarctation]. G Ital Cardiol (1987) 0.81
The ovarian cycle as a factor of variability in the laboratory screening for primary aldosteronism in women. J Hum Hypertens (2008) 0.81
Reprogramming of pig dermal fibroblast into insulin secreting cells by a brief exposure to 5-aza-cytidine. Stem Cell Rev (2014) 0.80
[Informatics support and teledialysis]. Minerva Urol Nefrol (1994) 0.80
Cardiac damage due to nonpenetrating trauma. Report of four cases. G Ital Cardiol (1987) 0.80
Impaired sympathetic response before intradialytic hypotension: a study based on spectral analysis of heart rate and pressure variability. Clin Sci (Lond) (1999) 0.80
Surgical angioplasty for isolated coronary ostial stenosis. Tex Heart Inst J (1997) 0.80
Expression and intracytoplasmic distribution of staufen and calreticulin in maturing human oocytes. J Assist Reprod Genet (2015) 0.80
Centrifugal pump and reduction of neurological risk in adult cardiac surgery. J Extra Corpor Technol (2001) 0.80
The NO+O3 reaction: a triple oxygen isotope perspective on the reaction dynamics and atmospheric implications for the transfer of the ozone isotope anomaly. J Chem Phys (2008) 0.79
Quantitative evaluation of left ventricular shape in anterior aneurysm. Cathet Cardiovasc Diagn (1993) 0.79
The relative contributions of menopause and aging to postmenopausal vertebral osteopenia. J Clin Endocrinol Metab (1993) 0.79
Primary fibrosarcoma of the heart. Chest (1972) 0.79
[Alport syndrome: 15-year follow-up in 28 cases]. Pediatr Med Chir (1987) 0.79
Why is it so difficult to derive pluripotent stem cells in domestic ungulates? Reprod Domest Anim (2012) 0.79
Endogenous stem and precursor cells for demyelinating diseases: an alternative for transplantation? Neurol Res (2006) 0.79